Protein kinase C (PKC) is an integral part of a major signal transduction pathway for external stimuli. PKC has been implicated in the proliferation and differentiation of both normal and leukemic hematopoietic cells. Phorbol esters (i.e., PMA), which bind to and activate PKC directly, can induce terminal differentiation of both promyelocytic leukemia HL-60 and erythroleukemia K562 cells. In contrast, bryostatin 1 (bryo), a non- phorbol ester PKC activator, stimulates continued cell division and blocks the cytostatic effects of PMA in these cell lines. The divergent effects of PMA and bryo correlate with the differential translocation and activation of alpha and beta11 PKC in response to PMA and bryo. PMA and bryo activate both alpha and beta11 PKC, however, bryo but not PMA causes selective translocation and activation of beta11 PKC at the nucleus. In the proposed studies the expression, cellular distribution and activation state of the major PKC isotypes (alpha, beta1, beta11, gamma and epsilon) will be examined in K562 cells during proliferation and PMA-induced megakaryocytic differentiation. The role of individual PKC isotypes in proliferation and differentiation will be probed by assessing the effect of overexpressing and inhibiting the expression of individual PKC isotypes on the proliferative and differentiation capacity of K562 cells. The molecular basis for the selective translocation and activation of beta11 PKC at the nucleus in response to bryo will be assessed by constructing and expressing alpha/beta11 PKC chimeras in K562 cells. PKC chimeras will be assayed for translocation and activation phenotype in response to PMA and bryo in intact cells. Likewise, PKC chimeras will be expressed in the baculovirus expression system, purified from Sf9 insect cells and characterized for co-factor requirements, activator responsiveness and substrate specificity in-vitro.
The aims of this proposal will be achieved using a combination of biochemical, immunological, pharmacological and molecular biological approaches.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA056869-03
Application #
2097649
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1992-04-01
Project End
1996-03-31
Budget Start
1994-04-01
Budget End
1996-03-31
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Fields, Alan P; Murray, Nicole R (2008) Protein kinase C isozymes as therapeutic targets for treatment of human cancers. Adv Enzyme Regul 48:166-78
Ray, Sutapa; Lu, Ying; Kaufmann, Scott H et al. (2004) Genomic mechanisms of p210BCR-ABL signaling: induction of heat shock protein 70 through the GATA response element confers resistance to paclitaxel-induced apoptosis. J Biol Chem 279:35604-15
Yu, Wangsheng; Murray, Nicole R; Weems, Capella et al. (2003) Role of cyclooxygenase 2 in protein kinase C beta II-mediated colon carcinogenesis. J Biol Chem 278:11167-74
Lu, Y; Jamieson, L; Brasier, A R et al. (2001) NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival. Oncogene 20:4777-92
Denning, G; Jamieson, L; Maquat, L E et al. (2001) Cloning of a novel phosphatidylinositol kinase-related kinase: characterization of the human SMG-1 RNA surveillance protein. J Biol Chem 276:22709-14
Ray, A; Fields, A P; Ray, B K (2000) Activation of transcription factor SAF involves its phosphorylation by protein kinase C. J Biol Chem 275:39727-33
Li, Q; Subbulakshmi, V; Fields, A P et al. (1999) Protein kinase calpha regulates human monocyte O-2 production and low density lipoprotein lipid oxidation. J Biol Chem 274:3764-71
Jamieson, L; Carpenter, L; Biden, T J et al. (1999) Protein kinase Ciota activity is necessary for Bcr-Abl-mediated resistance to drug-induced apoptosis. J Biol Chem 274:3927-30
Murray, N R; Fields, A P (1998) Phosphatidylglycerol is a physiologic activator of nuclear protein kinase C. J Biol Chem 273:11514-20
Gokmen-Polar, Y; Fields, A P (1998) Mapping of a molecular determinant for protein kinase C betaII isozyme function. J Biol Chem 273:20261-6

Showing the most recent 10 out of 18 publications